2023 Partnerships Portfolios 
The Dermatology Digest
SEPTEMBER 30, 2024
market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.
Spa Executive
NOVEMBER 10, 2023
As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. I am particularly thrilled about reshaping the very concept of design-driven well-being within our global portfolio. What are you most excited about?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Spa Executive
FEBRUARY 15, 2024
T he partnership between Infor Hospitality Management Solution and Book4Time is a step forward in improving guest experience and operational efficiency. This means a guest staying at one hotel can visit a spa at another hotel in your company portfolio and charge the experience back to the room at the hotel where they are staying.
Aesthetics Advisor
SEPTEMBER 15, 2023
Glenmark Pharmaceuticals has signed a partnership with Canadian company SaNOtize Research & Development Corp., This study is expected to wrap up by February 2023. As of June 2023, several COVID-19 nasal spray vaccines are being researched in studies — 16 intranasal and 2 inhaled to be exact.
Spa Executive
JANUARY 16, 2024
Prior to stepping into this position in June 2023, Ms. Jumeirah’s spas all have a Middle Eastern influence which also underpins the signature brand experience across the portfolio. Design is a core focus for Jumeirah which also extends within the wellness spaces in the portfolio.
The Dermatology Digest
DECEMBER 21, 2023
The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.
The Dermatology Digest
DECEMBER 21, 2023
The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.
Expert insights. Personalized for you.
36 
Let's personalize your content